The U.S. government is rapidly scaling its quotas for COVID-19 testing and relying on drugmakers and manufacturers to step up to the challenge. Now, CDMO Thermo Fisher Scientific has scored a U.S. contract to help produce a key tool for the ramped-up testing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,